
Transcatheter Embolization & Occlusion Device Market by Product (Accessories, Embolization Coils, Embolization Particles), Application (Neurology, Oncology, Peripheral Vascular Disease), End User - Global Forecast 2024-2030
Description
Transcatheter Embolization & Occlusion Device Market by Product (Accessories, Embolization Coils, Embolization Particles), Application (Neurology, Oncology, Peripheral Vascular Disease), End User - Global Forecast 2024-2030
The Transcatheter Embolization & Occlusion Device Market size was estimated at USD 5.29 billion in 2023 and expected to reach USD 5.94 billion in 2024, at a CAGR 12.76% to reach USD 12.28 billion by 2030.
Global Transcatheter Embolization & Occlusion Device Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Transcatheter Embolization & Occlusion Device Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transcatheter Embolization & Occlusion Device Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Transcatheter Embolization & Occlusion Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc, Artio Medical, Inc., Becton Dickinson and Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Medtronic PLC, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer Inc., Sanofi SA, Siemens AG, Stryker Corporation, Terumo Corporation, and The 3M Company.
Market Segmentation & Coverage
This research report categorizes the Transcatheter Embolization & Occlusion Device Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Accessories
Embolization Coils
Embolization Particles
Flow Diverter Devices
Liquid Embolics
Application
Neurology
Oncology
Peripheral Vascular Disease
Urology
End User
Ambulatory Surgical Centers
Clinics
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Transcatheter Embolization & Occlusion Device Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transcatheter Embolization & Occlusion Device Market?
3. What are the technology trends and regulatory frameworks in the Transcatheter Embolization & Occlusion Device Market?
4. What is the market share of the leading vendors in the Transcatheter Embolization & Occlusion Device Market?
5. Which modes and strategic moves are suitable for entering the Transcatheter Embolization & Occlusion Device Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
187 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Transcatheter Embolization & Occlusion Device Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing demand for minimally invasive surgeries
- 5.1.1.2. Increased burden of targeted diseases
- 5.1.1.3. Surge in incidence of cardiovascular diseases and respiratory disorders
- 5.1.2. Restraints
- 5.1.2.1. High cost of products
- 5.1.3. Opportunities
- 5.1.3.1. Technological advances in the devices with enhanced efficiency
- 5.1.3.2. Increasing adoption of TEO devices
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulatory procedures for product commercialization
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Transcatheter Embolization & Occlusion Device Market, by Product
- 6.1. Introduction
- 6.2. Accessories
- 6.3. Embolization Coils
- 6.4. Embolization Particles
- 6.5. Flow Diverter Devices
- 6.6. Liquid Embolics
- 7. Transcatheter Embolization & Occlusion Device Market, by Application
- 7.1. Introduction
- 7.2. Neurology
- 7.3. Oncology
- 7.4. Peripheral Vascular Disease
- 7.5. Urology
- 8. Transcatheter Embolization & Occlusion Device Market, by End User
- 8.1. Introduction
- 8.2. Ambulatory Surgical Centers
- 8.3. Clinics
- 8.4. Hospitals
- 9. Americas Transcatheter Embolization & Occlusion Device Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Transcatheter Embolization & Occlusion Device Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Transcatheter Embolization & Occlusion Device Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Agilent Technologies Inc
- 13.1.3. Artio Medical, Inc.
- 13.1.4. Becton Dickinson and Company
- 13.1.5. Boston Scientific Corporation
- 13.1.6. Edwards Lifesciences Corporation
- 13.1.7. Integer Holdings Corporation
- 13.1.8. Koninklijke Philips N.V.
- 13.1.9. Medtronic PLC
- 13.1.10. Merit Medical Systems, Inc.
- 13.1.11. Penumbra, Inc.
- 13.1.12. Pfizer Inc.
- 13.1.13. Sanofi SA
- 13.1.14. Siemens AG
- 13.1.15. Stryker Corporation
- 13.1.16. Terumo Corporation
- 13.1.17. The 3M Company
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET RESEARCH PROCESS
- FIGURE 2. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2023 VS 2030
- FIGURE 3. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET DYNAMICS
- FIGURE 7. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 12. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. TRANSCATHETER EMBOLIZATION & OCCLUSION DEVICE MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.